In-Depth Notes on Biofilm Formation by Uropathogenic Escherichia coli

Background

Uropathogenic Escherichia coli (UPEC) are the main cause of urinary tract infections (UTIs) in humans, either community-acquired or hospital-acquired. UPEC is a specific pathogenic strain of E. coli characterized by its ability to adhere to urinary tract tissues and form biofilms, which promote persistence and recurrence of infections.

The primary factor for UTI persistence and recurrence is biofilm formation, which protects UPEC from antimicrobial treatments and enhances its survival in the urinary tract environment. Biofilms are complex communities of bacteria encased in a protective extracellular matrix, making them more resistant to both the host immune response and conventional antibiotic therapies.

Objectives

To explore the genetic relatedness, biofilm formation capability, and biofilm-associated genes in UPEC collected from patients with hospital-acquired and community-acquired UTIs. This study aims to identify common virulence genes and their roles in the pathogenicity of UPEC to better understand how these infections can be managed and prevented in clinical settings.

Methods

  1. Bacterial Isolation: 100 UPEC isolates were obtained from urine samples (49 from inpatients, 51 from outpatients). The samples were cultured on selective media to isolate UPEC and confirm their identity through biochemical tests.

  2. Biofilm Formation: Assessed using the microtitre plate method, measuring optical density (OD) at 570 nm to quantify biofilm production. The method involves staining mature biofilms with crystal violet and measuring absorbance to determine the strength of biofilm formation.

  3. Genetic Analysis: Evaluated the genetic relatedness through Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR), allowing for the differentiation of UPEC strains based on their genetic profiles.

  4. Genes Analyzed: Common virulence genes associated with biofilm formation—fimH, papC, sfa/focDE, csgA, crl, afa, flu, and bcsA—were examined to determine their prevalence and association with biofilm production.

  5. Statistical Analysis: Used Pearson’s Chi-squared test or Fisher’s exact test, with a significance level (P-value) of <0.05. This analysis helped establish correlations between virulence gene presence and biofilm formation capability.

Findings

  1. Biofilm Production:

    • 99% of UPEC isolates exhibited biofilm formation—72 (72%) were weak, 20 (20%) moderate, and 7 (7%) strong biofilm producers. This highlights the predominant role of biofilm in UPEC pathogenesis.

    • Only 1% (1 isolate) failed to form a biofilm, demonstrating the resilience of UPEC in the urinary tract environment.

  2. Virulence Gene Prevalence:

    • bcsA (91%), crl (85%), fimH (82%), papC (80%), csgA (65%), flu (Ag43) (26%), afa (17%), and sfa/focDE (9%).

    • The only significant association with biofilm formation was the sfa/focDE gene (P=0.027) with moderate and strong biofilm producers, suggesting its critical role in biofilm development.

Observations on Genetic Relatedness

Higher genetic similarities were found among inpatient UPEC isolates compared to outpatients, indicating possible spread within hospital settings. This suggests that infection control measures may need to be strengthened in hospitals to prevent UTI outbreaks.

Main clusters identified suggest a relatedness in UPEC isolates between different hospital units, raising concerns about nosocomial infections and transmission dynamics among patients.

Conclusion

Biofilm formation plays a critical role in UPEC's ability to persist and complicate UTIs, necessitating consideration for therapeutic strategies that target biofilm in UTI management. Understanding the genetic diversity and virulence factors of UPEC can inform new treatment approaches and prevention strategies.

Importance of robust infection control measures in hospitals to reduce UTI occurrences due to UPEC. Enhanced surveillance and hygiene practices are essential to curtail the spread of these infections.

Key Takeaways

  • Biofilm Formation: Essential for UPEC survival against the immune response and treatment, making it a major target for intervention.

  • Virulence Factors: Understanding and targeting these can inform effective interventions to reduce UTI incidence.

  • Genetic Clustering: Insights into patterns of infection can help in outbreak management in healthcare settings and improve responses to UTI outbreaks.